CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...

The program involving the Dornsife School of Public Health, College of Nursing and Health Professions and the College of Medicine will combine public health qualitative and quantitative assessment and ...